1. Introduction {#sec1}
===============

Following the first report of radial coronary angiography by Campeau in 1989 and radial percutaneous coronary intervention (PCI) by Kiemeneij et al. in 1992, there is an increase in use of transradial access (TRA) because of lower access site bleeding, patient preference and satisfaction, early ambulation, reduced morbidity, and lower procedural cost over transfemoral approach around the world \[[@B1]--[@B3]\]. Lower mortality as shown in RIVAL trial with transradial coronary angioplasty (TRA) in acute coronary syndrome patients gives additional boost to it \[[@B4]\]. Most of the studies of the transradial approach have been performed through right radial route because of familiarity in performing the study from the patient\'s right side as commonly used in femoral approach though it can be done from left radial route as well. But it is not totally immune from criticism and complications. One of major criticisms of transradial approach is that it takes longer overall procedure and fluoroscopy time, which means more radiation exposure to cath lab personnel as they will also stand close to patient where rates of radiation scattered will be higher \[[@B5]\] So, the aim of this study was to evaluate the safety of transradial approach versus transfemoral approach in routine coronary angiography practice in terms of crossover rate from one to the other, contrast amount, overall procedure time, fluoroscopy time, and complications.

2. Material and Method {#sec2}
======================

2.1. Design {#sec2.1}
-----------

It was prospective, randomized, single-centre study conducted in the Department of Cardiology, LPS Institute of Cardiology, GSVM Medical College, Kanpur, U.P, India where all cases of diagnostic coronary angiography (CAG) of 1997 consecutive patients for various reasons over a 12 month period (from January 2015 till the end of December 2015) were reviewed for this analysis. The study protocol was approved by the local ethics committee and followed the Declaration of Helsinki after obtaining informed consent from each patient.

2.2. Procedure {#sec2.2}
--------------

Enrolled patients underwent comprehensive cardiac evaluation including CAG as a part of their diagnostic procedure and those who underwent subsequent PCI among ad hoc group were excluded. The choice between transfemoral or transradial artery access was operator\'s discretion with right radial approach being the default strategy. Transfemoral approach was favoured for patients with abnormal Allen test and with coronary artery bypass grafts (CABG).

Radial artery was punctured by 21 G needle and 0.021′′ guide wires (Cordis, USA) were inserted. 5-F sheath and 6-F sheath were used for diagnostic purpose and ad hoc intervention depending on need. After sheath replacement, cocktail containing 200 *μ*g nitroglycerin, 2.5 mg diltiazem, and 2500 IU unfractionated heparin was injected. Angiogram was performed by 5-F TIG catheter (Terumo, Japan). For those having abnormal take-off where cannulation was not possible with TIG catheter, Judkin\'s left or right (JL/JR) catheter was used. Radial sheath was removed just after procedure and compression was performed for 2 h with radial compression device (TR band; Terumo) using the "patent haemostasis" protocol proximal to puncture site ([Figure 1](#fig1){ref-type="fig"}) \[[@B4]\]. TR band was inflated with 15--19 mL of air. The patency of radial artery was checked at least once every 20 minutes by palpation and colour of palm and was removed after 2 hours of sheath removal. Light pressure bandage was applied which was removed next day.

Transfemoral procedures were performed by 5 Fr diagnostic catheters (JL/JR). At the end of the procedure, sheath was removed and manual compression was performed until satisfactory haemostasis had been achieved followed by placement of compressive bandage with dynaplast for 6 h. Patients were stratified into two groups, transradial and transfemoral, according to arterial access used to perform procedure. Crossover to transradial access was defined as failed access, extreme tortuosity and peripheral arterial disease ([Figure 2](#fig2){ref-type="fig"}).

Crossover to transfemoral access was defined as failure to cannulate through radial route and classified into the following three groups: puncture failure (lack of radial cannulation), radial and brachial failure (severe spasm, tortuosity, loops, remnant, or other anomalies), and epiaortic failure (severe subclavian or aortic tortuosity) ([Figure 3](#fig3){ref-type="fig"}) \[[@B6]\].

Procedure duration was defined as time between first needle skin contact to removal of last catheter. Total fluoroscopy time was recorded, as it is correlated to catheter manipulation. Angiographic and procedural details including severity of coronary artery disease and complexity of lesions were noted.

2.3. Statistical Evaluation {#sec2.3}
---------------------------

Statistical analyses were performed using the SPSS 17.0 (SPSS Inc., Chicago, Illinois). Continuous variables were analyzed using Student\'s *t*-test and presented as mean ± SD whereas categorical variables were given as numbers (percentages). The comparison between groups was done by Mann--Whitney *U* test for continuous variables and by Chi-square or Fisher\'s exact test for categorical variables. *p* \< 0.05 was considered statistically significant.

3. Result {#sec3}
=========

A total of 1997 consecutive patients were enrolled where transradial approach was used in 1076 patients (53.88%) and transfemoral approach in 921 patients (46.12%). Baseline characteristics of patients are summarized in [Table 1](#tab1){ref-type="table"}, which were similar in both groups except for cardiomyopathy (*n* = 7; 0.6% versus *n* = 38; 4.1%: *p* = 0.05), post-CABG (*n* = 7; 0.6% versus *n* = 31; 3.3%: *p* = 0.04), and valvular heart disease awaiting replacement (*n* = 4; 0.3% versus *n* = 23; 2.4%: *p* = 0.02) which were significantly higher in transfemoral than transradial group. All transradial access in post-CABG group were done by left radial approach.

Crossover from right radial artery access to femoral approach occurred in 31 cases (2.8%) because of puncture failure in 15 patients (1.4%), hairpin loop in 3 patients (0.27%), vasospasm (0.65%) in 7 patients, and epiaortic failure in 6 patients (0.6%) while there were 3 (0.3%) crossovers in the femoral group (*p* = 0.001) ([Figure 2](#fig2){ref-type="fig"}). Comparing the transradial and transfemoral approaches, fluoroscopy time (2.46 ± 1.22 versus 2.83 ± 1.31 min, *p* = 0.32), procedure duration (8.89 ± 2.72 versus 9.33 ± 2.82 min, *p* = 0.56), radiation dose (24.2 ± 4.21 versus 22.3 ± 3.46 Gycm^2^, *p* = 0.43), contrast volume (67.52 ± 22.54 versus 71.63 ± 25.41 mL, *p* = 0.32), and postprocedural serum creatinine (1.3 ± 0.2 versus 1.4 ± 0.15 mg/dL, *p* = 0.41) were not significantly different between both transradial and transfemoral groups ([Table 2](#tab2){ref-type="table"}).

28 patients (2.6%) developed vasospasm who responded to additional doses of nitroglycerin and diltiazem except in 7 patients who did not respond and went crossover to transfemoral route. Radial artery occlusion (RAO) was observed in 56 patients (5.2%) in whom pulse was palpable in 29 patients (51%) on next day. Local site pain (*n* = 21; 1.9% versus *n* = 38; 4.1%; *p* = 0.04), local haematoma (*n* = 9; 0.83% versus *n* = 13; 1.4%; *p* = 0.001), and local site paraesthesia (*n* = 13; 1.2% versus *n* = 19; 2.1%; *p* = 0.03) were significantly higher in transfemoral than transradial group.

4. Discussion {#sec4}
=============

Transradial approach for cardiac catheterization (TRC) is an appealing alternative to transfemoral access for both diagnostic and therapeutic purposes though it requires a steep learning curve initially. Because of its anatomy and inherent nature, technical challenges will always be there. Transradial access has been associated with a greater access crossover rate, which was reported to be 4%--7% in various studies \[[@B7]--[@B9]\]. Louvard et al. \[[@B10]\] reported the crossover from transradial to transfemoral approach in 8.9% and 8.1% vise versa in their patient\'s study. That might be because of octogenarian population, lesser number of patients enrolled, and mixed population of both angiography and percutaneous interventions. Kim and Yoon \[[@B11]\] in their study had crossover rate of 3.5% for TRC. In our study, however the crossover rate in TRC group was 2.8%, while there was 0.3% crossover in transfemoral group. This was because of proper selection of suitable radial cases, accurate puncture technique, gentle and delicate maneuver of catheter, and methods for dealing with tortuous epiaortic anatomy. Puncture failure is the first obstacle during the early learning period of transradial catheterization because radial artery, being small, is prone to spasm. Wrist pain at puncture site is an important factor leading to radial spasm and puncture failure. As puncture is the gateway of radial access, it should be near perfect. Also, improvements in device technology and increase in expertise have narrowed the gap of access site crossover from the earlier period of transradial access to the modern era.

Louvard et al. \[[@B10]\] reported that fluoroscopy time was longer in transradial group than transfemoral group (4.5 ± 3.7 versus 6.0 ± 4.4 min; *p* \< 0.05) for coronary angiography which sometimes becomes more demanding and longer in elderly patients because of the frequent presence of specific vascular abnormalities, calcification, or arterial loops. Plourde et al. \[[@B12]\] in their meta-analysis reported that transradial access was associated with a small but significant increase in fluoroscopy time for diagnostic coronary angiography which narrows down over time; the clinical significance of this small increase is uncertain and is unlikely to outweigh the clinical benefits of transradial access. Again, meta-regression analysis showed that overall difference in fluoroscopy time between the two procedures has decreased significantly by 75% over past two decades from 2 min to nearly 30 s (*p* \< 0.0001) because of expertise and improved hardware, an observation similarly noted by Agostoni et al. \[[@B13]\] and Brasselet et al. \[[@B14]\]. Fluoroscopy time in our study too among both groups was not significantly different.

The procedural duration (from first puncture attempt to removal of last catheter) was 9.87 minutes as reported by Chag and Gupta \[[@B15]\]. Similar were the observations made by Brueck et al. \[[@B16]\]. All of them noted that left radial approach consumes lesser time than right radial approach though, in our study, the majority were done by right radial approach with procedural time of 9.33 ± 2.82, not significantly different from transfemoral group. In our study, most of them were single wall puncture which is considered to be ideal; some of them were done through puncture and retraction technique as well. Single successful puncture in first attempt thus cutting down the procedural time might have made a difference as well.

Contrast volume during the procedure was not significantly different among both groups though lesser in transradial group as noted by Rao et al. \[[@B17]\] and Kawashima et al. \[[@B18]\]. The higher percentage of post-CABG patients in the transfemoral in our study may partly account for the higher though not significant contrast dose in the femoral group and the subsequent significant higher utilization of radiation dose during procedure to visualize the graft bypass vessels in addition to native coronary arteries. Also this explanation can be applied to procedural times, which were longer in the femoral than the radial group; however, it did not reach a statistically significant difference. Postprocedural serum creatinine did not show any significant rise among both groups to show that risk of contrast induced nephropathy remains the same in both of the groups.

Radiations doses and the combination of DAP (dose area product) fluoroscopy and DAP fluorography were not different among both groups though Brueck et al. \[[@B16]\] had reported higher radiation exposure in transradial than transfemoral group. This was partly offset by larger number of post CABG cases in transfemoral group. We performed all transradial procedures with single preshaped catheter (Tiger catheter) and therefore we cannot exclude that the use of this one could contribute to a further reduction in radiation exposure thereby equating the two \[[@B19]\]. Also the operator\'s experience plays a major role in the success rate and procedure duration and therefore radiation exposure.

Incidence of RAO and vasospasm were similar as reported by Brueck et al. \[[@B16]\]. When patients with RAO were further examined, pulse was still palpable in 51% of patients. Local complications (local site pain, haematoma, and local site paraesthesia) were significantly higher in transfemoral group as reported by Jolly et al. \[[@B4]\].

Our results are from a high volume centre experienced in the transradial approach, and results might look different from laboratory with lower experience in this approach. As for the beginner in the transradial approach, it may consume extra time to access the radial artery compared with the experienced ones, and the fluoroscopy time may be longer but, as for the femoral approach, after adequate training, this gap narrows.

5. Conclusion {#sec5}
=============

The transradial approach for coronary angiography is no longer merely an alternative strategy to transfemoral route but rather an excellent opportunity for operators to train for transradial coronary intervention.
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![(a) TR band; various internal diameters of radial artery (b, c, d, and e); RAO with collaterals (f).](CRP2016-4013843.001){#fig1}

![Few of the complications of transradial catheterization: vasospasm, focal (a); vasospasm, diffuse (b); perforation (c); dissection (d).](CRP2016-4013843.002){#fig2}

![Reasons of radial crossover from transfemoral route: tortuous and calcified aorta.](CRP2016-4013843.003){#fig3}

###### 

Baseline characteristics of patients (*n* = 1997).

  Characteristic                                 Transradial CAG (*n* = 1076; %)   Transfemoral CAG (*n* = 921; %)   *p* value
  ---------------------------------------------- --------------------------------- --------------------------------- -----------
  Age (years)                                    51 ± 16.4                         49 ± 14.9                         0.16
  Male                                           856 (79.6%)                       700 (71.7)                        0.2
  Female                                         220 (20.4%)                       221 (28.3)                        0.23
  Height (cm)                                    166.5 ± 10.8                      154 ± 8.4                         0.4
  Weight (kg)                                    63.6 ± 11.2                       59.2 ± 9.6                        0.18
  BMI (kg/m^2^)                                  24.9 ± 2.8                        23.8 ± 3.6                        0.4
  BSA (m^2^)                                     1.66 ± 0.22                       1.62 ± 0.19                       0.24
  Serum creatinine (mg/dL)                       1.2 ± 0.3                         1.3 ± 0.4                         0.4
  *CAD risk factors*                                                                                                  
  Hypertension                                   421 (39.1)                        313 (34 )                         0.32
  Diabetes mellitus                              358 (33.2)                        268 (29 )                         0.29
  Smokers                                        323 (30)                          323 (35 )                         0.31
  Family history of CAD                          76 (7.1)                          37 (4 )                           0.43
  Dyslipidemia                                   441 (41)                          335 (36.4 )                       0.22
  *Clinical diagnosis*                                                                                                
  Acute coronary syndrome                        676 (62.8)                        543 (58.9)                        0.12
  Chronic stable angina                          355 (33)                          240 (26.1)                        0.32
  Cardiomyopathy                                 07 (0.6)                          38 (4.1)                          0.05
  Chest pain for evaluation                      27 (2.5)                          46 (4.9)                          0.53
  Previous CABG                                  07 (0.6)                          31 (3.3)                          0.04
  Valvular heart disease                         4 (0.3)                           23 (2.4)                          0.02
  LVEF (%)                                                                                                            
   (a) \>45%                                     818 (76)                          646 (70.2)                        0.32
   (b) 35--45%                                   120 (11.2)                        154 (16.7)                        0.21
   (c) \<35%                                     138 (12.8)                        120 (13.1 )                       0.4
  *Medications*                                                                                                       
  Aspirin                                        1002 (93.2)                       708 (76.9)                        0.5
  Clopidogrel                                    55 (50.6)                         636 (69.1)                        0.3
  Prasugrel                                      132 (12.3)                        169 (18.4)                        0.11
  Ticagrelor                                     58 (5.8)                          29 (3.2)                          0.33
  Statin                                         981 (91.2)                        722 (78.4)                        0.7
  Beta-blocker                                   785 (72.9)                        620 (67.4)                        0.53
  ACEI/ARB                                       974 (90.5)                        754 (81.9)                        0.19
  CCB                                            230 (21.4)                        268 (29.2)                        0.5
  Aldosterone antagonist                         132 (12.3)                        84 (9.2)                          0.31
  *Angiographic severity of CAD (obstructive)*   743 (69.1)                        723 (78.6)                        0.42
   (a) SVD                                       350 (47.2)                        420 (58.2)                        0.18
   (b) DVD                                       212 (28.6)                        161 (22.2)                        0.56
   (c) TVD                                       181 (20.4)                        104 (14.3)                        0.67
   (d) Left main (isolated ± other vessel)       41 (3.8)                          38 (5.3 )                         0.3
  CAD (intermediate 50--70%)                     177 (16.4)                        103 (11.2)                        0.29
  Non-obs. CAD (recanalised)                     97 (8.9)                          38 (4.2)                          0.44
  Normal coronaries                              59 (5.4)                          55 (6)                            0.31

Data presented as mean ± standard deviation or number (percentage). BMI = body mass index; BSA = body surface area; CAD = coronary artery disease; DM = diabetes mellitus; LVEF = left ventricular ejection fraction; ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin-receptor blocker; CCB = calcium-channel blocker; SVD = single-vessel disease; DVD = double-vessel disease; TVD = triple-vessel; CABG = coronary artery bypass graft.

###### 

Procedural and postprocedural outcome of patients (*n* = 1, 997).

  Variables                                       Transradial CAG (*n* = 1076; %)   Transfemoral CAG (*n* = 921; %)   *p* value
  ----------------------------------------------- --------------------------------- --------------------------------- -----------
  Catheters used                                                                                                       
   (a) Single catheter                            1034 (96.1)                       10 (1.1)                          0.24
   (b) Catheter exchanged^**∗**^ (AL/AR/ JR/JL)   42 (4.9.)                         911 (98.9)                         
  Crossover rate                                                                                                       
   (a) Radial to femoral                          31 (2.9)                          ---                               0.001
   (b) Femoral to radial                          ---                               3 (0.3)                            
  UFH                                             1076 (100%)                       921 (100)                         0.22
  Duration of radial artery compression (Hr.)     2.1 ± 0.2                         ---                               0.12
  Fluoroscopy time (min)                          2.46 ± 1.22                       2.83 ± 1.31                       0.32
  Radiation dose (Gy × cm^2^)                     24.2 ± 4.21                       22.3 ± 3.46                       0.43
  Procedure duration                              8.89 ± 2.72                       9.33 ± 2.82                       0.56
  Contrast volume (mL)                            67.52 ± 22.54                     71.63 ± 25.41                     0.32
  Serum creatinine (mg/dL), post-CAG              1.3 ± 0.2 (6 ± 4.5)               1.4 ± 0.15 (8 ± 2.6)              0.41
  RAO                                             56 (5.2)                          ---                               ---
  Vasospasm                                       28 (2.6)                          ---                               ---
  *Local site complication*                       43 (3.9)                          70 (7.6)                          0.04
  Local site pain                                 21 (1.9)                          38 (4.1)                          0.04
  Haematoma                                       9 (0.83)                          13 (1.4)                          0.001
  Local site paraesthesia                         13 (1.2)                          19 (2.1)                          0.03

  ^**∗**^Including one for crossover; UFH: unfractionated heparin; CAG: Coronary Arteriography; RAO: radial artery occlusion.
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